JWCA has advised guardant health on capital market transactions with over $2.2 billion in transaction Value

November 2025: JWCA acts as Guardant Health on its upsized $402.5 million convertible exchange

February 2025: JWCA acts as sole exchange agent for Guardant Health on its $600 million overnight convertible exchange

November 2020: JWCA advises Guardant Health on its inaugural $1.15 million convertible and capped call